2Brown PD, Buckner JC, O' Fallon JR, et al.Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.Journal of Clinical Oncology, 2003,21(13):2519-2524.
3Tanakal K, Arao T, Tamura D, et al. Srpx2 is a novel Chondroitin sul- fate proteoglycan that is overexpressed in gastrointestinal cancer.An- nals of Oncology, 2012,23 (Suppl 11 ) : 132 - 167.
5Fernandes AT,Mitra N,Xanthopoulos E,et al. The impact of extent and location of mediastinal lymph node involvement on survival in stage II1 non-small cell lung cancer patients treated with definitive radiotherapy[ J]. Int J Radia Oncol Biol Phy,2012,83 ( 1 ) :340 - 347.
6Sekine I, Sumi M, Ito Y, et al. Phase i study of concurrent high-dose three-dimensional conforrnal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage IH non-small-cell lung cancer[ J]. Int J Radia Oncol Biol Phy,2012,82 (2) :953 - 959.
7Treat J,Scagliotti GV,Peng G,et al.Comparison of pemetrexed plus cisplatin with other first-line double in advanced non-small cell lung cancer(NSCLC):a combined analysis of three phase3 trials[J].Lung Cancer,2012,76(2):222-227.
8Yang M,Fan WF,Pu XL,et al.Significance of thymidylate synthase expression for resistance to pemetrexed in pulmonary adenocarinomap[J].Oncol Lett,2014,7(1):227-232.
9Senan S,Cardenal F,Vansteenkiste J,et al.A randomized phaseⅡstudy comparing induction or consolidation chemotherapy with cisplatin-docetaxel,plus radical concurrent chemoradiotherapy with cisplatin-docetaxel,in patients with unresectable locally advanced non-small-cell lung cancer[J].Ann Oncol,2011,22(3):553-558.
10Rodrigues-Pereira J,Kim JH,Magallanes M,et al.A randomized phase 3 trial comparing pemetrexed/carboplatin a n d d o c e t a x e l/c a r b o p l a t i n a s f i r s t-l i n e t r e a t m e n t f o r advanced,nonsquamous non-small cell lung cancer[J].J Thorac Oncol,2011,6(11):1907-1914.
